1
|
Lee MAB, Ng M, Yugendra P, Yao Y, Ponampalam R, Tan BKK. Hemorrhagic pancreatitis from fenofibrate and metformin toxicity: a case report. World J Emerg Med 2023; 14:495-498. [PMID: 37969214 PMCID: PMC10632758 DOI: 10.5847/wjem.j.1920-8642.2023.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Accepted: 06/26/2023] [Indexed: 11/17/2023] Open
Affiliation(s)
- Marcus Aik Beng Lee
- Department of Emergency Medicine, Singapore General Hospital, Singapore 169608, Singapore
| | - Mingwei Ng
- Department of Emergency Medicine, Singapore General Hospital, Singapore 169608, Singapore
| | - Paul Yugendra
- Department of Emergency Medicine, Singapore General Hospital, Singapore 169608, Singapore
| | - Yiju Yao
- Analytical Toxicology Laboratory, Health Sciences Authority, Singapore 169078, Singapore
| | - R Ponampalam
- Department of Emergency Medicine, Singapore General Hospital, Singapore 169608, Singapore
| | - Boon Kiat Kenneth Tan
- Department of Emergency Medicine, Singapore General Hospital, Singapore 169608, Singapore
| |
Collapse
|
2
|
Luan HH, Wang A, Hilliard BK, Carvalho F, Rosen CE, Ahasic AM, Herzog EL, Kang I, Pisani MA, Yu S, Zhang C, Ring AM, Young LH, Medzhitov R. GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance. Cell 2019; 178:1231-1244.e11. [PMID: 31402172 PMCID: PMC6863354 DOI: 10.1016/j.cell.2019.07.033] [Citation(s) in RCA: 321] [Impact Index Per Article: 53.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2018] [Revised: 05/02/2019] [Accepted: 07/17/2019] [Indexed: 12/21/2022]
Abstract
Growth and differentiation factor 15 (GDF15) is an inflammation-associated hormone with poorly defined biology. Here, we investigated the role of GDF15 in bacterial and viral infections. We found that inflammation induced GDF15, and that GDF15 was necessary for surviving both bacterial and viral infections, as well as sepsis. The protective effects of GDF15 were largely independent of pathogen control or the magnitude of inflammatory response, suggesting a role in disease tolerance. Indeed, we found that GDF15 was required for hepatic sympathetic outflow and triglyceride metabolism. Failure to defend the lower limit of plasma triglyceride levels was associated with impaired cardiac function and maintenance of body temperature, effects that could be rescued by exogenous administration of lipids. Together, we show that GDF15 coordinates tolerance to inflammatory damage through regulation of triglyceride metabolism.
Collapse
Affiliation(s)
- Harding H Luan
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
| | - Andrew Wang
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Medicine (Rheumatology), Yale University School of Medicine, New Haven, CT 06520, USA.
| | - Brandon K Hilliard
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Medicine (Rheumatology), Yale University School of Medicine, New Haven, CT 06520, USA
| | - Fernando Carvalho
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
| | - Connor E Rosen
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
| | - Amy M Ahasic
- Department of Medicine (Pulmonary, Critical Care and Sleep), Yale University School of Medicine, New Haven, CT 06520, USA
| | - Erica L Herzog
- Department of Medicine (Pulmonary, Critical Care and Sleep), Yale University School of Medicine, New Haven, CT 06520, USA
| | - Insoo Kang
- Department of Medicine (Rheumatology), Yale University School of Medicine, New Haven, CT 06520, USA
| | - Margaret A Pisani
- Department of Medicine (Pulmonary, Critical Care and Sleep), Yale University School of Medicine, New Haven, CT 06520, USA
| | - Shuang Yu
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
| | - Cuiling Zhang
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Medicine (Rheumatology), Yale University School of Medicine, New Haven, CT 06520, USA
| | - Aaron M Ring
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
| | - Lawrence H Young
- Department of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06520, USA; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT 06520, USA
| | - Ruslan Medzhitov
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA.
| |
Collapse
|
3
|
Párniczky A, Kui B, Szentesi A, Balázs A, Szűcs Á, Mosztbacher D, Czimmer J, Sarlós P, Bajor J, Gódi S, Vincze Á, Illés A, Szabó I, Pár G, Takács T, Czakó L, Szepes Z, Rakonczay Z, Izbéki F, Gervain J, Halász A, Novák J, Crai S, Hritz I, Góg C, Sümegi J, Golovics P, Varga M, Bod B, Hamvas J, Varga-Müller M, Papp Z, Sahin-Tóth M, Hegyi P. Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis. PLoS One 2016; 11:e0165309. [PMID: 27798670 PMCID: PMC5087847 DOI: 10.1371/journal.pone.0165309] [Citation(s) in RCA: 158] [Impact Index Per Article: 17.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2016] [Accepted: 10/10/2016] [Indexed: 12/28/2022] Open
Abstract
Objective The aim of this study was to analyse the clinical characteristics of acute pancreatitis (AP) in a prospectively collected, large, multicentre cohort and to validate the major recommendations in the IAP/APA evidence-based guidelines for the management of AP. Design Eighty-six different clinical parameters were collected using an electronic clinical research form designed by the Hungarian Pancreatic Study Group. Patients 600 adult patients diagnosed with AP were prospectively enrolled from 17 Hungarian centres over a two-year period from 1 January 2013. Main Results With respect to aetiology, biliary and alcoholic pancreatitis represented the two most common forms of AP. The prevalence of biliary AP was higher in women, whereas alcoholic AP was more common in men. Hyperlipidaemia was a risk factor for severity, lack of serum enzyme elevation posed a risk for severe AP, and lack of abdominal pain at admission demonstrated a risk for mortality. Abdominal tenderness developed in all the patients with severe AP, while lack of abdominal tenderness was a favourable sign for mortality. Importantly, lung injury at admission was associated with mortality. With regard to laboratory parameters, white blood cell count and CRP were the two most sensitive indicators for severe AP. The most common local complication was peripancreatic fluid, whereas the most common distant organ failure in severe AP was lung injury. Deviation from the recommendations in the IAP/APA evidence-based guidelines on fluid replacement, enteral nutrition and timing of interventions increased severity and mortality. Conclusions Analysis of a large, nationwide, prospective cohort of AP cases allowed for the identification of important determinants of severity and mortality. Evidence-based guidelines should be observed rigorously to improve outcomes in AP.
Collapse
Affiliation(s)
| | - Balázs Kui
- First Department of Medicine, University of Szeged, Szeged, Hungary
| | - Andrea Szentesi
- First Department of Medicine, University of Szeged, Szeged, Hungary.,Institute for Translational Medicine, University of Pécs, Pécs, Hungary
| | - Anita Balázs
- First Department of Medicine, University of Szeged, Szeged, Hungary
| | - Ákos Szűcs
- First Department of Surgery, Semmelweis University, Budapest, Hungary
| | - Dóra Mosztbacher
- Department of Pediatrics, Balassa János Hospital of County Tolna, Szekszárd, Hungary
| | - József Czimmer
- First Department of Medicine, University of Pécs, Pécs, Hungary
| | - Patrícia Sarlós
- First Department of Medicine, University of Pécs, Pécs, Hungary
| | - Judit Bajor
- First Department of Medicine, University of Pécs, Pécs, Hungary
| | - Szilárd Gódi
- First Department of Medicine, University of Pécs, Pécs, Hungary
| | - Áron Vincze
- First Department of Medicine, University of Pécs, Pécs, Hungary
| | - Anita Illés
- First Department of Medicine, University of Pécs, Pécs, Hungary
| | - Imre Szabó
- First Department of Medicine, University of Pécs, Pécs, Hungary
| | - Gabriella Pár
- First Department of Medicine, University of Pécs, Pécs, Hungary
| | - Tamás Takács
- First Department of Medicine, University of Szeged, Szeged, Hungary
| | - László Czakó
- First Department of Medicine, University of Szeged, Szeged, Hungary
| | - Zoltán Szepes
- First Department of Medicine, University of Szeged, Szeged, Hungary
| | - Zoltán Rakonczay
- First Department of Medicine, University of Szeged, Szeged, Hungary
| | - Ferenc Izbéki
- Szent György University Teaching Hospital of County Fejér, Székesfehérvár, Hungary
| | - Judit Gervain
- Szent György University Teaching Hospital of County Fejér, Székesfehérvár, Hungary
| | - Adrienn Halász
- Szent György University Teaching Hospital of County Fejér, Székesfehérvár, Hungary
| | - János Novák
- Pándy Kálmán Hospital of County Békés, Gyula, Hungary
| | - Stefan Crai
- Pándy Kálmán Hospital of County Békés, Gyula, Hungary
| | - István Hritz
- Bács-Kiskun County University Teaching Hospital, Kecskemét, Hungary
| | - Csaba Góg
- Healthcare Center of County Csongrád, Makó, Hungary
| | - János Sümegi
- Borsod-Abaúj-Zemplén County Hospital and University Teaching Hospital, Miskolc, Hungary
| | - Petra Golovics
- First Department of Medicine, Semmelweis University, Budapest, Hungary
| | | | | | | | | | - Zsuzsanna Papp
- Institute for Translational Medicine, University of Pécs, Pécs, Hungary
| | - Miklós Sahin-Tóth
- Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, United States of America
| | - Péter Hegyi
- First Department of Medicine, University of Szeged, Szeged, Hungary.,Institute for Translational Medicine, University of Pécs, Pécs, Hungary.,Hungarian Academy of Sciences - University of Szeged, Momentum Gastroenterology Multidisciplinary Research Group, Szeged, Hungary
| | | |
Collapse
|